Navigation Links
Drug Offers Hope for Alzheimer's disease

An experimental treatment for Alzheimer's may allow treatment at a later stage than other medications. The drug, known as Memantine, has been on the market for a decade in Germany// and was recently recommended for approval by the European Union's equivalent of the Food and Drug Administration.

Memantine works through a different mechanism than other, currently approved Alzheimer's drugs, such as Aricept, that have been shown to affect progression of early stage disease. The final devastating period, where Memantine may help, can also be the disease's most long lasting.

But researchers found that Alzheimer's patients who received Memantine deteriorated mentally at a considerably lower rate than patients who received placebo. While some are calling it a significant advance in the treatment of Alzheimer's disease, others remain much more cautious about the drug's potential and how it's benefits could be misinterpreted.

Forrest Pharmaceuticals, the U.S. manufacturer of the drug, is expected to file for FDA approval sometime this year. The company is also exploring uses for the drug in earlier stages of the disease and in conjunction with currently approved treatments.

Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Drug Firm Offers to Donate Smallpox Vaccine
3. fMRI Offers Insight Into An Infants Brain
4. Gel Offers A More Targeted Approach
5. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
6. Surgery Offers Better Treatment For Third Degree Piles
7. New Study Offers Hope For Balding Men
8. Gamma Knife Offers New Hope For Trigeminal Neuralgia Patients
9. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
10. CPHA Offers HIV Information Packages To Canadian Football League Teams
11. Blair Offers James Support To Fight AIDS
Post Your Comments:

(Date:11/29/2015)... , ... November 29, 2015 , ... While conventional walkers ... or provide ready access to exercise weights. Fortunately, an inventor from Uniontown, Pa., has ... TOMMY WALKER to enhance the benefits of a standard walker to improve the user’s ...
(Date:11/28/2015)... ... November 28, 2015 , ... ... and teleradiology services, has added Chris Hafey and Claude Hooton to its board ... Radiological Society of North America (RSNA) 2015 Annual Meeting and continues to strategically ...
(Date:11/27/2015)... , ... November 28, 2015 , ... There is only ... outperform our billings from last year? , This question has not been an easy ... coming to the retirement age and the younger workforce don’t share the same discipline ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... Aliso Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... exclusively for use in Final Cut Pro X. With ProSidebar: Fasion, video editors ... banners, or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)...  National Decision Support Company (NDSC) continues to ... notable statewide implementations. As a result, ordering providers ... more than 1 million times per month—all from ... provides real-time feedback on the most appropriate imaging ... implemented at over 100 healthcare systems nationally, representing ...
(Date:11/27/2015)... -- Research and Markets ( ) has announced ... 2015-2019" report to their offering. ... the author the present scenario and growth prospects of ... the market size, the report considers revenue generated from ... and copper IUDs. The report forecasts the global intrauterine ...
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
Breaking Medicine Technology: